MabCure's PIPE Round

MabCure raised a round of funding on January 20, 2011. Investors include Roswell Capital Partners.

MabCure is a U.S. biotechnology company whose mission is to change the perception of cancer as being a largely incurable disease. MabCure owns proprietary technology for the creation of unique and hig…

Articles about MabCure's PIPE Round: